THE INDIAN PHARMACIST Official Circular Pharmacy Logo THE INDIAN PHARMACISTLearn. Explore. Practise. Excel.
MEDICINE MONOGRAPH CODE: [10.4]-C108 ID: TIP-MED-000378

Multiminerals

Active Ingredient / Scientific Identity: Multiminerals • Class: Comprehensive Micronutrient Supplement (Fat-Soluble Vitamins A, D, E, K + Water-Soluble Vitamins B, C + Trace Minerals Zn, Mg, Se, Cu, Cr, Mn)

⚖️ Compare Profile
Generic / Entity NameMultiminerals ([10.4]-C108)
Verified Indian Brands / RefGeneric Compendial Entry (No Commercial Brand Claimed)
Pharmacological ClassComprehensive Micronutrient Supplement (Fat-Soluble Vitamins A, D, E, K + Water-Soluble Vi
Available Dosage FormsOral Film-Coated Tablets / Softgel Capsules & Syrups (Once-daily nutritional RDA / therapeutic formulations)
Regulatory ClassificationNon-Schedule / OTC or Schedule K Permitted Preparation (Medical Supervision Recommend
Key Warning & Review DateRenal: CRITICAL CKD WARNING: Standard over-the-counter multivitamins containing Vitamin A (Retinol), Potassium, or Magnesium
Reviewed: 2026-11-10
Safety Matrix:⚖️ Legal Status: Non-Schedule / OTC or Schedule K Permitted Preparati✔️ Standard Clinical Dispensing Precautions

1. Clinical & Scientific Overview

Multiminerals (TIP-MED-000378, Reference Code [10.4]-C108) is classified under Vitamins, Minerals & Nutritional Supplements (Ch 10) as a Comprehensive Micronutrient Supplement (Fat-Soluble Vitamins A, D, E, K + Water-Soluble Vitamins B, C + Trace Minerals Zn, Mg, Se, Cu, Cr, Mn). Within the Indian regulatory and compendial framework, it is governed under Non-Schedule / OTC or Schedule K Permitted Preparation (Medical Supervision Recommended for High-Dose/Therapeutic Regimens).

Verified Indian Market Examples / Compendial Status:
Co-indexed constituent under primary monograph [10.4] (Multivitamins and Multiminerals). Representative Indian Market Examples (Edition 2.7 Ch 10 [10.4], p. 128): Supradyn (Bayer), Zincovit (Apex), Revital-H (Sun Pharma—contains Ginseng), A to Z NS (Alkem), Becadexamin (GSK), Maxirich — Strengths & Dosage Forms: Oral Film-Coated Tablets / Softgel Capsules & Syrups (Once-daily nutritional RDA / therapeutic formulations)
Co-indexed constituent under primary monograph [10.4] (Multivitamins and Multiminerals). Representative Indian Market Examples (Edition 2.7 Ch 10 [10.4], p. 128): Supradyn (Bayer), Zincovit (Apex), Revital-H (Sun Pharma—contains Ginseng), A to Z NS (Alkem), Becadexamin (GSK), Maxirich — Strengths & Dosage Forms: Oral Film-Coated Tablets / Softgel Capsules & Syrups (Once-daily nutritional RDA / therapeutic formulations)
Dosage Forms & Available Strengths:
Oral Film-Coated Tablets / Softgel Capsules & Syrups (Once-daily nutritional RDA / therapeutic formulations)
Routes: Oral / Parenteral / Topical per formulation

3. Mechanism of Action & Pharmacodynamics

Comprehensive Micronutrient Supplement (Fat-Soluble Vitamins A, D, E, K + Water-Soluble Vitamins B, C + Trace Minerals Zn, Mg, Se, Cu, Cr, Mn) acting on target receptor/enzyme pathways in Vitamins, Minerals & Nutritional Supplements (Ch 10): clinical efficacy is mediated via Comprehensive Micronutrient Supplement (Fat-Soluble Vitamins A, D, E, K + Water-Soluble Vitamins B, C + Trace Minerals Zn, Mg, Se, Cu, Cr, Mn) for Micronutrient convalescence following acute infectious illness, surgery, burns, or trauma; documented dietary inadequacy, frailty, or anorexia in the elderly; malabsorption states..

4. Therapeutic Indications & Evidence-Supported Uses

  • Micronutrient convalescence following acute infectious illness, surgery, burns, or trauma
  • documented dietary inadequacy, frailty, or anorexia in the elderly
  • malabsorption states

🇮🇳 Jurisdiction & Indication Note: Indications and schedules reflect Indian compendial and regulatory records (CDSCO / Indian Pharmacopoeia & NFI / NLEM 2022). Where international reference labels (US FDA DailyMed / NCBI StatPearls) are cited for pharmacokinetic or mechanistic parameters, international approvals do not automatically imply CDSCO approval in India.

5. Educational Dosage Context, Formulations & Administration

Educational Dosing & Regimen Summary: General Adult Reference: 1 tablet or capsule once daily after a meal. Follow physician prescription.

Administration & Meal Timing: Take WITH or immediately AFTER breakfast or lunch (meals provide dietary fat for absorption of Vitamins A, D, E, and K, and prevent zinc/iron-induced empty-stomach nausea). | Once daily after breakfast or lunch (avoid bedtime if the brand contains Ginseng [e.g., Revital-H], which causes insomnia and blood pressure/heart rate elevation!).

6. Pharmacokinetics, Metabolism & Renal/Hepatic Adjustment

Absorption & Disposition:
Follows class pharmacokinetic profile detailed in parent monograph [10.4].
Metabolism & Biotransformation:
Renal: CRITICAL CKD WARNING: Standard over-the-counter multivitamins containing Vitamin A (Retinol), Potassium, or Magnesium MUST BE AVOIDED in advanced CKD (Stages 4–5 / Dialysis)! (The failing kidney cannot excrete retinol-binding protein, leading to Vitamin A toxicity, hypercalcaemia, and bone resorption!). Hepatic: Avoid high-dose Vitamin A and iron in chronic liver disease.
Elimination & Renal Adjustment:
Renal: CRITICAL CKD WARNING: Standard over-the-counter multivitamins containing Vitamin A (Retinol), Potassium, or Magnesium MUST BE AVOIDED in advanced CKD (Stages 4–5 / Dialysis)! (The failing kidney cannot excrete retinol-binding protein, leading to Vitamin A toxicity, hypercalcaemia, and bone resorption!). Hepatic: Avoid high-dose Vitamin A and iron in chronic liver disease.
Hepatic Impairment Considerations:
Renal: CRITICAL CKD WARNING: Standard over-the-counter multivitamins containing Vitamin A (Retinol), Potassium, or Magnesium MUST BE AVOIDED in advanced CKD (Stages 4–5 / Dialysis)! (The failing kidney cannot excrete retinol-binding protein, leading to Vitamin A toxicity, hypercalcaemia, and bone resorption!). Hepatic: Avoid high-dose Vitamin A and iron in chronic liver disease.

7. Contraindications, Precautions & High-Risk Warnings

Contraindications & Red-Flag Precautions:
  • Contraindicated in hypervitaminosis A or D, hypercalcaemia, haemochromatosis/iron overload (if iron-containing), and Wilson's disease (if copper-containing). Pregnancy Teratogenicity Warning: High-dose Retinol (Vitamin A >10,000 IU/day) in general adult multivitamins is teratogenic in the first trimester—pregnant women must ONLY take dedicated prenatal supplements! Avoid Retinol (Vitamin A) containing multivitamins in Chronic Kidney Disease!

Key Clinical Precautions: Renal: CRITICAL CKD WARNING: Standard over-the-counter multivitamins containing Vitamin A (Retinol), Potassium, or Magnesium MUST BE AVOIDED in advanced CKD (Stages 4–5 / Dialysis)! (The failing kidney cannot excrete retinol-binding protein, leading to Vitamin A toxicity, hypercalcaemia, and bone resorption!). Hepatic: Avoid high-dose Vitamin A and iron in chronic liver disease.

8. Adverse Effects Profile

Common & Mechanism-Related Adverse Effects:
  • Mild nausea (if taken on empty stomach due to zinc/copper/iron salts), bright yellow urine (riboflavin), dark stools (if iron-containing).
  • Hypervitaminosis A (headache, hepatotoxicity, bone pain, teratogenicity with chronic excess), chelation failure of concurrent antibiotics/thyroxine, ginseng-induced hypertension/tachycardia/hypoglycaemia.
Serious / Dose-Limiting Adverse Effects:

    9. Major Drug–Drug, Drug–Food & Drug–Herb Interactions

    • Chelation Hazard from Divalent Minerals (Zinc, Iron, Magnesium, Calcium) inside Multivitamins: Multivitamin-multimineral tablets chelate Levothyroxine, Fluoroquinolones (ciprofloxacin, levofloxacin), Tetracyclines (doxycycline), and Bisphosphonates—never swallow a multivitamin with the morning thyroid tablet or with an antibiotic (space by ≥2–4 hours)! Vitamin K inside certain multivitamins can mildly antagonise Warfarin if started/stopped erratically
    • Biotin interferes with TSH/troponin lab assays

    10. Clinical Monitoring, Patient Counselling & Storage

    Clinical & Laboratory Monitoring: Monitor clinical parameters per parent monograph [10.4].

    Pharmacist Patient Counselling Points:

    • Patient Counselling Checklist: Schedule multivitamin tablets after lunch (1:30–2:00 PM) so the zinc, magnesium, and iron minerals inside them are safely separated by ≥4 hours from early-morning Levothyroxine or morning antibiotics. Advise hypertensive, diabetic, and cardiac CGHS patients to avoid OTC ginseng-containing tonics without physician approval.
    • Meal & Clock Timing Instruction: Take WITH or immediately AFTER breakfast or lunch (meals provide dietary fat for absorption of Vitamins A, D, E, and K, and prevent zinc/iron-induced empty-stomach nausea). (Once daily after breakfast or lunch (avoid bedtime if the brand contains Ginseng [e.g., Revital-H], which causes insomnia and blood pressure/heart rate elevation!).)
    • Missed Dose Protocol: Skip the missed dose and resume the next day with a meal.
    • Geriatric Dispensing Pearl: Under CGHS guidelines, routine tonic/antioxidant multivitamins are restricted unless specifically indicated. Perform a strip-by-strip audit to stop duplicate vitamin combinations in elderly patients.

    Storage, Stability & Dispensing Safeguards: Store below 25°C–30°C in original moisture- and light-resistant packaging out of reach of children. Available forms: Oral Film-Coated Tablets / Softgel Capsules & Syrups (Once-daily nutritional RDA / therapeutic formulations)

    11. Visual Pharmacology & Mechanism Diagram (svg-v339-01-adme-12-step-journey)

    THE 12-STEP ORAL DRUG JOURNEY THROUGH THE HUMAN BODY (LADME) Note: IV bolus enters Step 6 directly (F = 100%); Sublingual & Transdermal routes bypass Step 4–5 Portal First-Pass Metabolism 1. Oral Administration • Tablet / Capsule swallowed • Gastric emptying to duodenum pH 1.5–3.5 (Stomach) 2. Disintegration & Dissolution • Tablet breaks into granules • API dissolves in GI fluid Noyes-Whitney Dissolution Rate 3. GI Epithelial Absorption • Crosses intestinal villi • Passive / Active / P-gp efflux Small Intestine (Large Surface Area) 4. Portal Circulation • Mesenteric veins → Portal vein • Delivers blood to liver sinusoids Pre-systemic Venous Conduit 5. First-Pass Metabolism • Gut & hepatic CYP450 extraction • High: GTN, Propranolol, Morphine Determines Bioavailability (F = f_a × (1-E_H)) 6. Systemic Circulation • Hepatic vein → IVC → Heart • Unbound vs Albumin-bound drug Only FREE drug is active 7–8. Tissue Distribution (Vd) • Capillary permeation to organs • Blood-Brain & Placental barriers Vd = Dose / C_0 (L or L/kg) 9. Target Site of Action • Receptors (GPCR, Ion channel) • Enzymes & Carrier Transporters Pharmacodynamic Effect (E_max, EC50) 10. Hepatic Biotransformation • Phase I (CYP450 Oxidation/Hydrolysis) • Phase II (Glucuronidation/Sulfation) Converts lipophilic drug → hydrophilic metabolite 11. Renal & Biliary Elimination • Nephron: Filtration + Secretion − Reabsorption • Biliary excretion & Enterohepatic recycling Total Clearance CL_tot = CL_renal + CL_hepatic 12. Excretion from the Body • Urine (Primary polar metabolite route) • Bile/Faeces, Expired Air, Sweat, Milk Elimination Half-Life t1/2 = (0.693 × Vd) / CL
    svg-v339-01-adme-12-step-journey — 8.1 Complete 12-Step Journey of an Orally Administered Drug (ADME): Figure 8.1: The 12-step physiological journey of a typical orally administered solid dosage form through Liberation, Absorption, Distribution, Metabolism, and Excretion (LADME). Note: Parenteral (IV), sublingual, and inhalational routes bypass gastrointestinal absorption and/or hepatic first-pass metabolism.

    12. Authoritative References, Regulatory Sources & Editorial Disclaimer

    Primary Compendial & Guideline Reference: Indian Pharmacopoeia (IP 2022) • NFI • CDSCO

    Official Verification Portals: Indian Pharmacopoeia Commission (IPC) & National Formulary of India (NFI) • Central Drugs Standard Control Organization (CDSCO) • Ministry of Health & Family Welfare — NLEM 2022 • NCBI Bookshelf / StatPearls Pharmacology Reference • DailyMed (US FDA Official Prescribing Reference)

    Last Medically & Pharmaceutically Reviewed: 2026-11-10 • Verification Status: VERIFIED_EDUCATIONAL_CONTENT

    Educational & Clinical Disclaimer: This reference profile is published solely for pharmacy education, academic study, and professional clinical reference. It does not substitute for patient-specific clinical judgement, qualified specialist oncology/medical supervision, or official CDSCO/IP prescribing information. Never self-medicate with prescription, Schedule H/H1/X, NDPS, or oncology medicines.